< Back to previous page
Researcher
Lisa Moris
- Disciplines:Urology and nephrology not elsewhere classified, Andrology, Cancer biology
Affiliations
- Department of Cellular and Molecular Medicine (Department)
Member
From2 Aug 2020 → 14 Jun 2022 - Laboratory of Molecular Endocrinology (Division)
Member
From1 Aug 2016 → 31 Jul 2020
Projects
1 - 1 of 1
- Clinical and preclinical studies of modulators of high-risk prostate cancer with metastatic potentialFrom1 Aug 2016 → 29 Apr 2022Funding: BOF - doctoral mandates, Private funding of national origin - undefined
Publications
1 - 10 of 53
- Evaluation of Oncological Outcomes and Data Quality in Studies Assessing Nerve-sparing Versus Non-Nerve-sparing Radical Prostatectomy in Nonmetastatic Prostate Cancer: A Systematic Review(2022)
Authors: Lisa Moris
Pages: 690 - 700 - Genomic Features of Lung-Recurrent Hormone-Senstive Prostate Cancer(2022)
Authors: Lisa Moris
- Patient- and Tumour-related Prognostic Factors for Urinary Incontinence After Radical Prostatectomy for Nonmetastatic Prostate Cancer: A Systematic Review and Meta-analysis(2022)
Authors: Lisa Moris
Pages: 674 - 689 - Clinical and preclinical studies of modulators of high-risk prostate cancer with metastatic potential(2022)
Authors: Lisa Moris, Frank Claessens, Steven Joniau
- Antizyme Inhibitor 1 Regulates Matrikine Expression and Enhances the Metastatic Potential of Aggressive Primary Prostate Cancer(2022)
Authors: Lisa Moris, Bram Boeckx, Diether Lambrechts, Christine Helsen, Bart Ghesquière, Stefaan Soenen, Elien Smeets, Roy Eerlings, Sarah El Kharraz, Hendrik Van Poppel, et al.
Pages: 527 - 541 - Systematic Review of Active Surveillance for Clinically Localised Prostate Cancer to Develop Recommendations Regarding Inclusion of Intermediate-risk Disease, Biopsy Characteristics at Inclusion and Monitoring, and Surveillance Repeat Biopsy Strategy(2022)
Authors: Lisa Moris
Pages: 337 - 346 - Diagnostic and prognostic factors in patients with prostate cancer: a systematic review(2022)
Authors: Lisa Moris
- Small-molecule profiling for steroid receptor activity using a universal steroid receptor reporter assay(2022)
Authors: Roy Eerlings, Tien Nguyen, Elien Smeets, Lisa Moris, Sarah El Kharraz, Arnout Voet, Wim Dehaen, Frank Claessens, Christine Helsen
- Updating and Integrating Core Outcome Sets for Localised, Locally Advanced, Metastatic, and Nonmetastatic Castration-resistant Prostate Cancer: An Update from the PIONEER Consortium(2022)
Authors: Lisa Moris
Pages: 503 - 514 - Neoadjuvant hormonal therapy before radical prostatectomy in high-risk prostate cancer(2021)
Authors: Gaëtan Devos, Gert De Meerleer, Marcella Baldewijns, Lisa Moris, Hendrik Van Poppel, Charlien Berghen, Wouter Everaerts, Frank Claessens, Steven Joniau
Pages: 739 - 762